ANIFROLUMAB REDUCES DISEASE ACTIVITY IN MULTIPLE ORGAN DOMAINS IN MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

被引:0
|
作者
Merrill, J. [1 ]
Furie, R. [2 ]
Werth, V. [3 ,4 ]
Khamashta, M. [5 ]
Drappa, J. [6 ]
Wang, L. [6 ]
Illei, G. [6 ]
机构
[1] Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA
[2] Northwell Hlth, Great Neck, NY USA
[3] Philadelphia VA Med Ctr, Philadelphia, PA USA
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] Graham Hughes Lupus Res Lab, Div Womens Hlth, London, England
[6] MedImmune, Gaithersburg, MD USA
关键词
novel therapy; interferon; efficacy;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
S2:04
引用
收藏
页码:S4 / S4
页数:1
相关论文
共 50 条
  • [41] ANTIPHOSPHOLIPID SYNDROME (APS) IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) LEADS TO A MORE SEVERE DISEASE
    Riancho-Zarrabeitia, Leyre
    Martinez Taboada, Victor
    Rua-Figueroa, Inigo
    Sanchez-Alonso, Fernando
    Galindo-Izquierdo, Maria
    Ovalles, Juan
    Olive, Alejandro
    Fernandez-Nebro, Antonio
    Calvo, Jaime
    Menor Almagro, Raul
    Tomero Muriel, Eva
    Uriarte Isacelaya, Esther
    Boteanu, Alina
    Andres, Mariano
    Freire Gonzalez, Mercedes
    Santos Soler, Gregorio
    Ruiz Lucea, Esther
    Ibanez Barcelo, Monica
    Castellvi, Ivan
    Galisteo, Carles
    Quevedo Vila, Victor
    Raya, Enrique
    Narvaez, J.
    Exposito, Lorena
    Hernandez Beriain, Jose A.
    Horcada, Loreto
    Pego-Reigosa, Jose M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 204 - 205
  • [42] ANTIPHOSPHOLIPID SYNDROME (APS) IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) LEADS TO A MORE SEVERE DISEASE
    Riancho-Zarrabeitia, Leyre
    Martinez Taboada, Victor
    Rua Figueroa, Inigo
    Alonso, Fernando
    Galindo, Maria
    Fernandez-Nebro, Antonio
    Calvo, Jaime
    Menor Almagro, Raul
    Pego Reigosa, Jose Maria
    [J]. LUPUS, 2019, 28 : 17 - 17
  • [43] PATTERNS OF DISEASE ACTIVITY IMPACT ON ORGAN DAMAGE IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Bortoluzzi, A.
    Padovan, M.
    Silvagni, E.
    Scire, C. A.
    Govoni, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 582 - 583
  • [44] Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus
    Morand, Eric F.
    Abreu, Gabriel
    Furie, Richard A.
    Golder, Vera
    Tummala, Raj
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (05) : 639 - 645
  • [45] EFFICACY AND SAFETY OF ANIFROLUMAB IN PATIENTS WITH MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF THE SECOND PHASE 3 RANDOMIZED CONTROLLED TRIAL
    Morand, Eric F.
    Furie, Richard
    Tanaka, Yoshiya
    Bruce, Ian N.
    Askanase, Anca D.
    Richez, Christophe
    Bae, Sang-Cheol
    Brohawn, Mr Philip Z.
    Pineda, Lilia
    Berglind, Anna
    Tummala, Raj
    [J]. INTERNAL MEDICINE JOURNAL, 2020, 50 : 22 - 23
  • [46] Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus
    Morand, E. F.
    Abreu, G.
    Furie, R. A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (05)
  • [47] Maintenance azathioprine reduces the incidence of relapse in systemic lupus erythematosus (SLE).
    GardnerMedwin, J
    Powell, RI
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1362 - 1362
  • [48] Systemic Lupus Erythematosus (SLE) Responder Index [SRI(4)] Response Is Associated with Global Benefit in Patients with Moderate to Severe SLE
    Furie, R.
    Wang, L.
    Drappa, J.
    Illei, G.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [49] SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) RESPONDER INDEX [SRI(4)] RESPONSE IS ASSOCIATED WITH GLOBAL BENEFIT IN PATIENTS WITH MODERATE TO SEVERE SLE
    Furie, R.
    Wang, L.
    Drappa, J.
    Illei, G.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S87 - S87
  • [50] Efficacy and Safety of Anifrolumab in Patients with Moderate to Severe Systemic Lupus Erythematosus: Results of the Second Phase 3 Randomized Controlled Trial
    Morand, Eric
    Furie, Richard
    Tanaka, Yoshiya
    Bruce, Ian
    Askanase, Anca
    Riche'z, Christophe
    Bae, Sang-Cheol
    Brohawn, Philip
    Pineda, Lilia
    Berglind, Anna
    Tummala, Raj
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71